AFP and hepatocellular carcinoma: In 2006, Iizuka et al. [31] demonstrated that cfDNA was able to identify HCC in a cohort of HCV positive patients with a sensitivity of 69.2% and a specificity of 93.3% (AUC = 0.90), both higher than those of AFP.